1
1
2
Prevalence and incidence Palpable nodules: 4-7% of the population Incidentally on US: almost 50 %,
75 % multi nodular, 25 % solitary Thyroid cancer: 5-10 % of palpable nodules The main objective of evaluating thyroid nodules is to
exclude malignancy
3
Type of thyroid nodules
Cyst: simple cyst, mixed cystic-solid Colloid nudule: dominant nodule in MNGAdenoma: Follicular, Hurthle cell, Atypical Thyroiditis: Hashimoto’s, subacute Infection: Granulomatous disease, Abscess Developmental anomalies: unilateral lobe agenesis,
cystic hygroma, Dermoid, TeratomaCarcinoma: papillary (75%), follicular ( 5-10%),
medullary (5-10%), anaplastic (5%),lymphoma (5%), metastatic
4
Factors associated with increase risk for malignant thyroid nodule History (moderate increase risk)
Age < 20 or > 60 years Male sex Exposure of RT (especially in childhood) F.Hx of thyroid cancer or polyposis
Physical finding (highly increase risk) larger than 3 cm Rapid tumor growth Very firm nodule, irregular surface Fixation to adjacent structure Symptom of local invasion: dysphagia, hoarseness Cervical lymphadenopathy Cold nodule on thyroid scan Solid or complex cyst on US
5
Factors suggesting benign thyroid nodule
F.Hx of autoimmune disease (Hashimoto’s thyroiditis) F.Hx of benign thyroid nodule or goiter Presense of thyroid hormone dysfunction,
hypothyroid or hyperthyroid Pain or tenderness associated with nodule Soft, smooth, mobile MNG without a predominant nodule Warm nodule on thyroid scan Simple cyst on US
6
Investigation1. Laboratory evaluation
TSH: screening for hyper or hypothyroidT3, T4 : when TSH are low normal or high normalSerum antithyroid peroxidase (anti-TPO),
antithyroglobulin (anti-Tg) if suspected thyroiditis 2. Imaging study
CT, MRI, PET: not cost-effective in initial evaluation of thyroid nodule
Ultrasound: characters that increase risk for malignant; ill defined margin, irregular shape, solid echo, hypoechoic,calcification (fine): sensitivity 75 %, specificity 61 %
Thyroid isotope scanning: 131 I, 123I, 99TC
cold nodule (84%): cancer risk 15%warm nodule (10.5%): cancer risk 9%hot nodule (5.5%): cancer risk 1%
Thyroxine suppression therapy with US follow up
sensitivity 83%, specificity 33%
7
US:US: A solitary hypoechoic nodule at A solitary hypoechoic nodule atRt. Lobe thyroidRt. Lobe thyroid
Slide 12Slide 12
8
Isotope scanIsotope scan: Left: Normal thyroid: Left: Normal thyroid
Right: A cold nodule Right: A cold nodule Lt.lobe thyroidLt.lobe thyroid
9
Diagnostic procedure:
Fine needle aspiration cytology (FNA)
Sensitivity: 70-90%, specificity 70-90% False negative result: 3-8 % Reliability depend on:
Operator Cytopathologist Type of tumor: follicular neoplasm has
20-30% false negative rate
10
Thyroid Nodule
TSH test
Euthyroid Thyrotoxic
Thyroid scan
FNA Cold nodule Hot nodule
131 I or surgeryBenign Suspicious Malignant Inadequate
Observe or T4-Px Surgery Repeat FNAFU 6-12 M
Suggested strategy for the management of thyroid nodules
11
Thyroid incedentalomas
Incidence: 30-60% (Autopsy), 13-50% (Ultrasound) Size: usually < 1.5 cm Incidence of cancer: < 5 %, mostly papillary CA
Thyroid incedentaloma
Hx. H+N RT, F.Hx. CA thyroid
Positive Negative
US guide FNA US finding
CytologySuspected Benign appearance
Malignant or (< 1.5 cm)(> 1.5 cm)
Observe
Malignant Benign
Surgery Observe
12
Frequency Malignant histologyBenign 60-65% 3-8 %
Colloid or nodule goiter Thyroiditis
Suspicious 10-15% 20-30% Follicular neoplasm Hurthle cell lesion Cellular smear Lymphoma
Malignant 3-5% 95% Papillary Medullary Anaplastic
Inadequate 15% 5% Techincal problem Degernerative nodule Hemorrhagic cyst
Result of thyroid FNA interpretation
13
Colloid nodule:
A: FNA B: Histopathology
14
Hoshimoto’s thyroiditis
A: FNA B: Histopathology
15
Papillary carcinoma:
A: FNA B: Histopathology
16
A: FNA B: Follicular adenoma
C: Follicular carcinoma